Inogen (INGN)
(Delayed Data from NSDQ)
$10.47 USD
-0.28 (-2.60%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $10.48 +0.01 (0.10%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth B Momentum A VGM
Company Summary
Goleta, CA-based Inogen Inc. develops, manufactures and markets portable oxygen concentrators (POCs). POCs are used by patients who suffer from chronic respiratory conditions and need LTOT. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen.
Inogen’s flagship portable devices Inogen One G3 and G2 weigh approximately 4.8 and 7.0 pounds and have up to 4.5 and 5 hours of battery life, respectively. Being portable, these devices can be charged anywhere. Inogen began to follow a Direct-to-Consumer strategy post its acquisition of Comfort Life Medical Supply, LLC in 2009.
Company Summary
Goleta, CA-based Inogen Inc. develops, manufactures and markets portable oxygen concentrators (POCs). POCs are used by patients who suffer from chronic respiratory conditions and need LTOT. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen.
Inogen’s flagship portable devices Inogen One G3 and G2 weigh approximately 4.8 and 7.0 pounds and have up to 4.5 and 5 hours of battery life, respectively. Being portable, these devices can be charged anywhere. Inogen began to follow a Direct-to-Consumer strategy post its acquisition of Comfort Life Medical Supply, LLC in 2009.
Inogen’s expanding product portfolio is a key catalyst. The company provides oxygen concentrator solutions for portable and stationary use. Inogen’s flagship product, One G4 is a single-solution POC. Recently, the company launched the Inogen One G5 in the domestic business-to-business arm.Management also confirmed Inogen’s plan of incorporating the Tidal Assist Ventilator directly into the Inogen One POCs and making the SideKick TAV product compatible with the Inogen At-Home Stationary Concentrator.
2023 at a Glance
Revenues were $315.7 million in 2023, down 16.3% from 2022.
Revenues at the Sales segment amounted to $251.6 million (79.7% of net sales, down 21.5% from FY22), while Rental revenues were $64.1 million (20.3%, up 12.9%).
General Information
Inogen, Inc
859 WARD DRIVE
GOLETA, CA 93111
Phone: 805-562-0500
Fax: NA
Email: ir@inogen.net
Industry | Medical - Instruments |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 11/5/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | -0.51 |
Current Year EPS Consensus Estimate | -1.92 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 11/5/2024 |
Price and Volume Information
Zacks Rank | |
Yesterday's Close | 10.75 |
52 Week High | 13.33 |
52 Week Low | 4.13 |
Beta | 1.05 |
20 Day Moving Average | 160,804.16 |
Target Price Consensus | 9.50 |
4 Week | -12.03 |
12 Week | 34.88 |
YTD | 95.81 |
4 Week | -14.23 |
12 Week | 29.43 |
YTD | 63.47 |
Shares Outstanding (millions) | 23.72 |
Market Capitalization (millions) | 254.98 |
Short Ratio | NA |
Last Split Date | NA |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | NA |
Change in Payout Ratio | NA |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | NA |
Trailing 12 Months | NA |
PEG Ratio | NA |
vs. Previous Year | 42.86% |
vs. Previous Quarter | 61.29% |
vs. Previous Year | 6.13% |
vs. Previous Quarter | 13.76% |
Price/Book | 1.35 |
Price/Cash Flow | NA |
Price / Sales | 0.78 |
6/30/24 | -45.37 |
3/31/24 | -42.87 |
12/31/23 | -38.98 |
6/30/24 | -28.57 |
3/31/24 | -28.44 |
12/31/23 | -27.03 |
6/30/24 | 2.70 |
3/31/24 | 2.70 |
12/31/23 | 2.86 |
6/30/24 | 2.37 |
3/31/24 | 2.36 |
12/31/23 | 2.55 |
6/30/24 | -28.30 |
3/31/24 | -30.07 |
12/31/23 | -30.61 |
6/30/24 | -28.30 |
3/31/24 | -30.07 |
12/31/23 | -32.46 |
6/30/24 | -28.39 |
3/31/24 | -30.14 |
12/31/23 | -32.42 |
6/30/24 | 7.96 |
3/31/24 | 8.15 |
12/31/23 | 8.79 |
6/30/24 | 7.94 |
3/31/24 | 7.56 |
12/31/23 | 6.55 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |
6/30/24 | 0.00 |
3/31/24 | 0.00 |
12/31/23 | 0.00 |